A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis (Q36469043)

14 August 2017

A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis (English)

1 reference

Elisabeth Steinhagen-Thiessen

14 August 2017

0 references

1 reference

1 reference

series ordinal

3

object named as

E Steinhagen-Thiessen

1 reference

14 August 2017

I Missala

1

1 reference

PMCID

3523136

14 August 2017

U Kassner

series ordinal

2

1 reference

14 August 2017

5 December 2012

1 reference

International journal of rheumatology

14 August 2017

1 reference

14 August 2017

2012

1 reference

14 August 2017

480784

1 reference

Creative Commons Attribution 3.0 Unported

14 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Farnesoid X receptor represses hepatic human APOA gene expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lipid profile in Tunisian patients with rheumatoid arthritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Screening and therapeutic management of lipoprotein(a) excess: review of the epidemiological evidence, guidelines and recommendations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lipoprotein(a) as a cardiovascular risk factor: current status

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lipoprotein (a) as an acute phase reactant in patients on chronic hemodialysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

FXR an emerging therapeutic target for the treatment of atherosclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Extended-release niacin or ezetimibe and carotid intima-media thickness.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lipoprotein (a) and apolipoprotein (a) in primary antiphospholipid syndrome.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

The role of beta2-glycoprotein I (beta2GPI) in the activation of plasminogen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Quo vadis haemapheresis. Current developments in haemapheresis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Autoimmunity, oxidized LDL and cardiovascular disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Beta2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lipoprotein(a) and its role in atherothrombotic disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

The antiphospholipid syndrome: ten years on.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lp(a) lipoprotein in cardiovascular disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lipoprotein (a). Heterogeneity and biological relevance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Macrophages and Oxidized Low Density Lipoproteins in the Pathogenesis of Atherosclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Designing a study to evaluate the effect of apheresis in patients with elevated lipoprotein(a).

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lipoprotein[a] and the lipid profile in patients with systemic sclerosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN).

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

[Changes in lipoprotein (a) [Lp(a)] level after an ischemic stroke].

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

[Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels]

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3523136

Lipoprotein(a) levels in systemic lupus erythematosus

21 October 2018

1 reference

12 December 2020

Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome

1 reference

12 December 2020

Clinical significance of the serum lipoprotein(a) level in patients with systemic lupus erythematosus: its elevation during disease flare

1 reference

12 December 2020

Is a (n inborn) deficiency of prostacyclin synthesis stimulating plasma factor associated with increased lipoprotein(a)?

1 reference

12 December 2020

Increased factor VIIa levels in systemic lupus erythematosus patients with lupus anticoagulant

1 reference

12 December 2020

beta(2)-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis

1 reference

12 December 2020

Lipoprotein (a) and acute-phase response in patients with vestibular neuronitis

1 reference

12 December 2020

Lipoprotein(a) and HLA-DRB1 and -DQB1 genes in coronary artery disease

1 reference

12 December 2020

Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome

1 reference

12 December 2020

Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis

1 reference

12 December 2020

Lipid profiles in untreated patients with rheumatoid arthritis

1 reference

12 December 2020

Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia

1 reference

12 December 2020

Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis

1 reference

12 December 2020

Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis

1 reference

12 December 2020

Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation

1 reference

12 December 2020

Increased serum levels of β₂-GPI-Lp(a) complexes and their association with premature atherosclerosis in patients with rheumatoid arthritis

1 reference

12 December 2020

Lipoprotein(a) complexes with beta2-glycoprotein I in patients with coronary artery disease

1 reference

12 December 2020

Detection of serum beta(2)-GPI-Lp(a) complexes in patients with systemic lupus erythematosus

1 reference

12 December 2020

Three different LDL apheresis columns efficiently and equally reduce lipoprotein(a) concentrations in patients with familial hypercholesterolemia and small apolipoprotein(a) particles

1 reference

12 December 2020

Dynamics of plasma lipoproteins and lipids during double filtration plasmapheresis (DEP)

1 reference

12 December 2020

Lipoprotein(a) in relation to acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica

1 reference

12 December 2020

Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis

1 reference

12 December 2020

Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome

1 reference

12 December 2020

High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction

1 reference

12 December 2020

Echocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus

1 reference

12 December 2020

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

12 December 2020

Lipoprotein(a) predicts the risk of thrombogenic complications in nephrotic syndrome

1 reference

12 December 2020

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/480784

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

3523136